Author

G. Washko

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy.

Elexacaftor/Tezacaftor/Ivacaftor (ETI) and other highly effective modulator therapies have transformed outcomes for people with cystic fibrosis (pwCF), yielding significant pulmonary and extrapulmonary benefits. Although lung transplant (LTx) rates have declined dramatically in the post ETI era, a substantial number of...

John C. Kennedy, A. Taddesse, A. Coppolino et al. · Journal of Cystic Fibrosis · 0 citations

Open access Sep 2026

Pulmonary Artery Dilation on Chest CT Across the Spectrum of Chronic Lung Disease.

BACKGROUND Pulmonary artery (PA) dilation on CT has been associated with pulmonary hypertension (PH) in subjects without lung disease using outdated PH criteria. The relationship between PA size and PH in chronic lung disease is unclear. RESEARCH QUESTION Is PA size associated with PH in subjects with chronic lung di...

T. J. Couch, G. Beck, E. Rosenzweig et al. · Chest · 0 citations